Health & Biotech
CardieX pumped up with insto support for $4.33 million raise – announces additional purchase plan for shareholders
Health & Biotech
ASX Health Stocks: Imaging stocks Clarity and Optiscan rally on trial, FDA news
Health & Biotech
ASX Health Stocks: Big announcements as Invex and Antisense jump over 20pc this morning
Health & Biotech
HealthKick Podcast: Bionomic charges forward with lead drug candidate treatment for PTSD and social anxiety
Health & Biotech
Reaching new heights: Nutritional Growth Solutions launches into 403 select Walmart stores in US
Health & Biotech
Singular Health’s 3Dicom FDA submission could open door to US$885.2m medical imaging software market
Health & Biotech
CLARITY 2.0 Covid-19 study involving Dimerix’s lead drug concludes patient recruitment
Health & Biotech
ASX Health Stocks: Respiri lifts 14pc after giving update on US market
Health & Biotech
Neurotech International appoints industry expert during key phase of growth
Health & Biotech
PharmAust says MPL can double the life expectancy of dogs with cancer; US trials to begin
Health & Biotech
Power move: Incannex attracts global regulatory affairs expert, Novo Nordisk exec to board
Health & Biotech
Neuroscientific Biopharma receives $1.13m in R&D incentive to progress EmtinB
Featured Health & Biotech Stocks
Health & Biotech
Healthcare stocks are as varied as the solutions they are working to solve. The sector covers biotech stocks developing breakthrough pharmaceutical drugs and vaccines to medtech companies launching the latest and greatest medical devices they hope will change the face of healthcare.
Even the ‘budding’ medical cannabis industry is in the mix as researchers explore new applications and treatments.
If you want to know what’s happening with emerging health stocks on the ASX, Stockhead has you covered, with daily stock news, expert insight and research. You can also recap broader industry trends and recent share price movements across the sector in our regular ‘Check Up’ feature.
Accurate, up-to-date news stories are important, especially in the health sector where progress is often slow and risk often high. That’s why we’re focused on helping small cap investors make sense of the medical jargon.